TG Therapeutics, Inc.

82
Strong Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US88322Q1085
USD
30.45
-1.06 (-3.36%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Million
Consolidated - Profit And Loss Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Operating Income
616.00
329.00
233.00
2.00
6.00
0.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
616.00
329.00
233.00
2.00
6.00
0.00
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Raw Materials Consumed
0.00
0.00
0.00
0.00
0.00
0.00
Power & Fuel Cost
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
Operating Expenses
26.00
24.00
12.00
10.00
5.00
6.00
General and Administration Expenses
232.00
154.00
122.00
69.00
128.00
107.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
492.00
287.00
213.00
195.00
351.00
273.00
Operating Profit (PBDIT) excl Other Income
123.00
41.00
20.00
-192.00
-344.00
-273.00
Other Income
11.00
8.00
4.00
3.00
0.00
0.00
Operating Profit (PBDIT)
136.00
50.00
25.00
-188.00
-343.00
-272.00
Interest
26.00
24.00
12.00
10.00
5.00
6.00
Profit before Depriciation and Tax
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
1.00
0.00
0.00
0.00
0.00
0.00
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
107.00
25.00
13.00
-198.00
-348.00
-279.00
Provision for Tax
-339.00
2.00
0.00
0.00
0.00
0.00
Profit After Tax
447.00
23.00
12.00
-198.00
-348.00
-279.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
0.00
0.00
0.00
0.00
0.00
0.00
Profit Available for appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Appropriations
0.00
0.00
0.00
0.00
0.00
0.00
Equity Dividend (%)
Earnings Per Share
2.77
0.15
0.09
-1.46
-2.63
-2.42
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 87.32% vs 40.80% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 194.13% vs 103.21% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 11.23% vs 90.47% in Dec 2024

stock-summary

Profit After Tax

YoY Growth in year ended Dec 2025 is 1,812.41% vs 84.52% in Dec 2024

Compare Profit and Loss Results of TG Therapeutics, Inc.
Markets Mojo
Figures in Million
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
Operating Income
616.00
588.00
28.00
4.76%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
616.00
588.00
28.00
4.76%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0.00
0.00
0%
Raw Materials Consumed
0.00
0.00
0.00
0%
Power & Fuel Cost
0.00
0.00
0.00
0%
Employee Cost
0.00
0.00
0.00
0%
Operating Expenses
26.00
0.00
26.00
0%
General and Administration Expenses
232.00
193.00
39.00
20.21%
Selling and Distribution Expenses
0.00
0.00
0.00
0%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
492.00
331.00
161.00
48.64%
Operating Profit (PBDIT) excl Other Income
123.00
257.00
-134.00
-52.14%
Other Income
11.00
24.00
-13.00
-54.17%
Operating Profit (PBDIT)
136.00
320.00
-184.00
-57.50%
Interest
26.00
0.00
26.00
0%
Profit before Depriciation and Tax
0.00
0.00
0.00
0%
Depreciation
1.00
38.00
-37.00
-97.37%
Profit Before Taxation & Exceptional Items
0.00
0.00
0.00
0%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
107.00
283.00
-176.00
-62.19%
Provision for Tax
-339.00
69.00
-408.00
-591.30%
Profit After Tax
447.00
214.00
233.00
108.88%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
0.00
0.00
0.00
0%
Profit Available for appropriations
0.00
0.00
0.00
0%
Appropriations
0.00
0.00
0.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
2.7704
1.6842
1.09
64.49%
Profit And Loss - Net Sales
Net Sales 616.29 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 87.32% vs 40.80% in Dec 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 123.32 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 194.13% vs 103.21% in Dec 2024

Profit And Loss - Interest
Interest 26.73 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 11.23% vs 90.47% in Dec 2024

Profit And Loss - Profit After Tax
Profit After Tax 447.18 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 1,812.41% vs 84.52% in Dec 2024